The University of Chicago Header Logo

Yasmin Hasan

Concepts (230)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brachytherapy
11
2026
139
2.610
Why?
Uterine Cervical Neoplasms
11
2025
326
2.530
Why?
Radiotherapy Planning, Computer-Assisted
11
2020
215
1.380
Why?
Endometrial Neoplasms
4
2025
243
1.350
Why?
Genital Neoplasms, Female
3
2025
118
1.120
Why?
Chemoradiotherapy
5
2020
337
1.000
Why?
Breast Neoplasms
15
2021
3303
0.990
Why?
Radiotherapy Dosage
10
2025
478
0.820
Why?
Radiation Oncology
5
2026
130
0.800
Why?
Radiation Injuries
5
2021
160
0.750
Why?
Radiosurgery
3
2025
352
0.670
Why?
Vaccines, DNA
1
2020
19
0.620
Why?
Human papillomavirus 18
1
2020
22
0.620
Why?
Human papillomavirus 16
1
2020
46
0.610
Why?
Cell Hypoxia
1
2020
191
0.590
Why?
Safety
1
2020
138
0.580
Why?
Radiotherapy, Intensity-Modulated
6
2025
200
0.580
Why?
Radiotherapy
3
2016
325
0.550
Why?
Radiometry
2
2016
64
0.520
Why?
Female
44
2025
51997
0.480
Why?
Cone-Beam Computed Tomography
3
2020
80
0.430
Why?
Patient Acceptance of Health Care
1
2017
315
0.390
Why?
Radiotherapy, Conformal
4
2020
88
0.380
Why?
Adenocarcinoma
2
2018
1215
0.380
Why?
Humans
49
2026
98799
0.370
Why?
Carcinoma, Squamous Cell
3
2018
1107
0.370
Why?
Middle Aged
27
2025
29642
0.350
Why?
Radiography, Thoracic
1
2014
331
0.350
Why?
Aged, 80 and over
14
2025
7461
0.350
Why?
Aged
23
2025
21986
0.330
Why?
Lymph Nodes
2
2016
563
0.330
Why?
Mastectomy, Segmental
3
2011
119
0.330
Why?
Radiation Dosage
3
2025
233
0.310
Why?
Neoplasm Staging
9
2021
2087
0.290
Why?
Adult
21
2025
29698
0.290
Why?
Radiation Tolerance
1
2010
179
0.290
Why?
Skin
3
2024
592
0.280
Why?
Dietary Supplements
1
2010
152
0.280
Why?
Sexism
2
2019
65
0.280
Why?
Oxygen
2
2026
777
0.270
Why?
Biological Products
1
2010
191
0.250
Why?
Prostheses and Implants
1
2007
132
0.250
Why?
Treatment Outcome
11
2025
9806
0.240
Why?
Radiobiology
1
2026
15
0.240
Why?
Bone and Bones
1
2007
272
0.240
Why?
Prostate
1
2010
434
0.240
Why?
Proton Therapy
1
2025
44
0.220
Why?
Organs at Risk
2
2016
55
0.220
Why?
Retrospective Studies
11
2025
11104
0.220
Why?
Prostatic Neoplasms
2
2021
1846
0.220
Why?
Cisplatin
3
2018
578
0.210
Why?
Lymphoma, T-Cell, Cutaneous
1
2024
31
0.210
Why?
Nocebo Effect
1
2024
5
0.210
Why?
Radiation, Ionizing
1
2024
123
0.210
Why?
Drugs, Generic
1
2024
21
0.210
Why?
Mammography
1
2007
505
0.200
Why?
Dysbiosis
1
2024
104
0.200
Why?
Radiotherapy, Adjuvant
3
2021
325
0.190
Why?
Tumor Burden
2
2017
330
0.180
Why?
Mental Health
1
2024
222
0.180
Why?
Heart
3
2018
527
0.170
Why?
Anxiety
1
2024
376
0.170
Why?
Radiotherapy, Image-Guided
1
2021
66
0.160
Why?
Hysterectomy
2
2020
175
0.160
Why?
Rectum
3
2016
152
0.160
Why?
Young Adult
7
2024
7598
0.160
Why?
Standard of Care
1
2021
71
0.160
Why?
Papillomavirus E7 Proteins
1
2020
31
0.160
Why?
Oncogene Proteins, Viral
1
2020
34
0.150
Why?
Neoplasms
2
2026
3382
0.150
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2023
2666
0.150
Why?
Carcinoma, Endometrioid
2
2019
60
0.150
Why?
Oximetry
1
2020
90
0.150
Why?
Carcinoma, Non-Small-Cell Lung
2
2021
1177
0.150
Why?
Depression
1
2024
625
0.150
Why?
Multimodal Imaging
1
2020
115
0.150
Why?
Tomography, X-Ray Computed
4
2020
2680
0.140
Why?
Dilatation
1
2019
47
0.140
Why?
Lymphatic Metastasis
1
2020
519
0.140
Why?
Hematologic Neoplasms
1
2023
384
0.140
Why?
Microbiota
1
2024
473
0.140
Why?
Breast
2
2011
317
0.140
Why?
Constriction, Pathologic
1
2019
214
0.140
Why?
Urethral Neoplasms
1
2018
10
0.140
Why?
Physicians, Women
1
2019
68
0.140
Why?
Breath Holding
1
2018
26
0.140
Why?
Postoperative Care
2
2017
239
0.140
Why?
Methylprednisolone
1
2018
65
0.130
Why?
Positron-Emission Tomography
1
2020
354
0.130
Why?
Lymphoma, T-Cell, Peripheral
1
2018
34
0.130
Why?
Vagina
1
2019
188
0.130
Why?
Diffusion Magnetic Resonance Imaging
1
2020
305
0.130
Why?
Thoracic Wall
2
2014
26
0.130
Why?
Deoxycytidine
1
2018
218
0.130
Why?
Colon, Sigmoid
1
2016
7
0.120
Why?
Polycythemia Vera
1
2016
22
0.120
Why?
Carcinoma, Transitional Cell
1
2018
158
0.120
Why?
Urinary Bladder
2
2016
263
0.120
Why?
Repressor Proteins
1
2020
450
0.120
Why?
Drug Substitution
1
2016
30
0.120
Why?
Hydroxyurea
1
2016
233
0.120
Why?
Hyperlipidemias
1
2016
93
0.120
Why?
Patient Care Planning
1
2016
92
0.120
Why?
Hematopoietic Stem Cell Transplantation
1
2023
979
0.120
Why?
Lung Neoplasms
2
2021
2474
0.110
Why?
Pyrazoles
1
2016
162
0.110
Why?
Practice Patterns, Physicians'
1
2021
669
0.110
Why?
Lung
2
2014
1409
0.110
Why?
Contrast Media
1
2020
1014
0.110
Why?
Neoplasm Grading
1
2017
425
0.110
Why?
Radiotherapy Setup Errors
1
2014
2
0.110
Why?
Hematologic Diseases
1
2015
77
0.110
Why?
Combined Modality Therapy
2
2017
1754
0.110
Why?
United States
5
2021
8387
0.100
Why?
DNA-Binding Proteins
1
2020
1275
0.100
Why?
Patient Positioning
1
2014
68
0.100
Why?
Neoplasm Recurrence, Local
2
2023
1538
0.100
Why?
Databases, Factual
2
2021
1102
0.100
Why?
Protein-Tyrosine Kinases
1
2015
305
0.100
Why?
Male
13
2024
47475
0.100
Why?
Disease-Free Survival
2
2013
1196
0.100
Why?
Data Interpretation, Statistical
1
2014
312
0.090
Why?
Equipment Design
1
2014
428
0.090
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2016
406
0.090
Why?
Hodgkin Disease
1
2013
144
0.090
Why?
Feasibility Studies
3
2026
818
0.090
Why?
Surgical Instruments
2
2014
70
0.090
Why?
Radiodermatitis
1
2011
10
0.090
Why?
Neoplasms, Multiple Primary
1
2012
100
0.090
Why?
Proto-Oncogene Proteins
1
2015
687
0.090
Why?
Practice Guidelines as Topic
2
2020
1116
0.080
Why?
Trigeminal Neuralgia
1
2011
11
0.080
Why?
Transcutaneous Electric Nerve Stimulation
1
2011
18
0.080
Why?
Colony-Forming Units Assay
1
2010
39
0.080
Why?
Fatigue
2
2024
187
0.080
Why?
Kaplan-Meier Estimate
1
2012
909
0.080
Why?
Clinical Trials, Phase III as Topic
1
2010
172
0.080
Why?
Clinical Protocols
1
2010
156
0.080
Why?
Multivariate Analysis
1
2012
1007
0.080
Why?
Imaging, Three-Dimensional
1
2014
634
0.070
Why?
Organ Specificity
1
2010
287
0.070
Why?
Brain Neoplasms
1
2015
845
0.070
Why?
Time Factors
2
2021
5586
0.070
Why?
Obesity
2
2014
1079
0.070
Why?
Carcinoma, Ductal, Breast
1
2007
167
0.060
Why?
Epithelial Cells
1
2010
710
0.060
Why?
Needles
1
2026
43
0.060
Why?
Adolescent
4
2024
10168
0.060
Why?
Cell Line
1
2010
2484
0.060
Why?
Cross Infection
1
2007
155
0.060
Why?
Reproducibility of Results
3
2018
2799
0.060
Why?
Magnetic Resonance Imaging
2
2020
3622
0.060
Why?
Tumor Hypoxia
1
2026
53
0.060
Why?
Wakefulness-Promoting Agents
1
2024
1
0.050
Why?
Placebo Effect
1
2024
37
0.050
Why?
Uncertainty
1
2024
81
0.050
Why?
Cell Proliferation
1
2010
1801
0.050
Why?
RNA, Ribosomal, 16S
1
2024
270
0.050
Why?
Electron Spin Resonance Spectroscopy
1
2026
340
0.050
Why?
Cell Line, Tumor
1
2010
2913
0.050
Why?
Adaptation, Psychological
1
2024
190
0.050
Why?
Mastectomy
2
2016
277
0.050
Why?
Melphalan
1
2023
98
0.050
Why?
Vidarabine
1
2023
107
0.050
Why?
Prospective Studies
4
2014
4837
0.050
Why?
Survival Analysis
2
2018
1530
0.050
Why?
Respiration
2
2018
274
0.040
Why?
Severity of Illness Index
2
2021
2025
0.040
Why?
Child
3
2024
7771
0.040
Why?
Prone Position
1
2020
62
0.040
Why?
Bacteria
1
2024
547
0.040
Why?
Genomics
1
2026
914
0.040
Why?
Uterus
1
2021
233
0.040
Why?
Scandinavian and Nordic Countries
1
2019
8
0.040
Why?
Women's Rights
1
2019
8
0.040
Why?
Age Factors
1
2024
1976
0.040
Why?
Attention
1
2024
435
0.040
Why?
Skin Neoplasms
1
2024
638
0.040
Why?
Workflow
1
2020
88
0.040
Why?
Salaries and Fringe Benefits
1
2019
32
0.040
Why?
Body Mass Index
2
2014
869
0.040
Why?
Cystadenocarcinoma, Serous
1
2019
69
0.040
Why?
Spirometry
1
2018
78
0.030
Why?
Vincristine
1
2018
102
0.030
Why?
Survival Rate
2
2013
2057
0.030
Why?
Prednisone
1
2018
252
0.030
Why?
Cyclophosphamide
1
2018
285
0.030
Why?
Doxorubicin
1
2018
285
0.030
Why?
Kinetics
1
2019
1478
0.030
Why?
Faculty, Medical
1
2019
197
0.030
Why?
Risk Factors
2
2019
6295
0.030
Why?
Nitriles
1
2016
172
0.030
Why?
Pelvis
1
2016
106
0.030
Why?
Cross-Over Studies
1
2016
394
0.030
Why?
Lymphatic Irradiation
1
2014
7
0.030
Why?
Rotation
1
2014
95
0.030
Why?
Follow-Up Studies
2
2013
4049
0.030
Why?
Gene Rearrangement
1
2015
175
0.030
Why?
Pyrimidines
1
2016
416
0.030
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2014
137
0.020
Why?
Acute Disease
1
2015
864
0.020
Why?
Child, Preschool
2
2013
4053
0.020
Why?
Double-Blind Method
1
2016
1793
0.020
Why?
Chicago
1
2016
1520
0.020
Why?
Mice
1
2026
12762
0.020
Why?
Comorbidity
1
2015
1037
0.020
Why?
Organ Size
1
2011
370
0.020
Why?
Longitudinal Studies
1
2015
1305
0.020
Why?
Age Distribution
1
2011
211
0.020
Why?
Analysis of Variance
1
2012
890
0.020
Why?
Vinblastine
1
2010
84
0.020
Why?
Regression Analysis
1
2011
578
0.020
Why?
Incidence
1
2015
1798
0.020
Why?
Sensitivity and Specificity
1
2014
1946
0.020
Why?
Confidence Intervals
1
2010
221
0.020
Why?
Internship and Residency
1
2019
1132
0.020
Why?
Pain Measurement
1
2011
403
0.020
Why?
Carboplatin
1
2010
331
0.020
Why?
Fluorouracil
1
2010
543
0.020
Why?
Case-Control Studies
1
2013
2017
0.020
Why?
Quality of Life
1
2016
1904
0.020
Why?
Biomarkers
1
2014
2026
0.020
Why?
Esthetics
1
2007
52
0.020
Why?
Pakistan
1
2007
18
0.020
Why?
Drug Resistance, Bacterial
1
2007
89
0.010
Why?
Animals
1
2026
29045
0.010
Why?
Movement
1
2007
317
0.010
Why?
Proportional Hazards Models
1
2007
925
0.010
Why?
Intensive Care Units
1
2007
476
0.010
Why?
Antineoplastic Agents
1
2010
2386
0.010
Why?
Hasan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (230)
Explore
_
Co-Authors (40)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_